Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT01931306 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT01931306
- Sponsor
- Boehringer Ingelheim
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.